Home

smutne akčné pokus tops animalaria rozprávanie odporovať Celzia

Scientists Hijacked Tobacco Plants to Make Malaria Drugs | Smart News| Smithsonian Magazine
Scientists Hijacked Tobacco Plants to Make Malaria Drugs | Smart News| Smithsonian Magazine

Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles | ACS Central Science
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles | ACS Central Science

Synthesis and Antimalarial Activity of 4-Methylaminoquinoline Compounds against Drug-Resistant Parasite | ACS Omega
Synthesis and Antimalarial Activity of 4-Methylaminoquinoline Compounds against Drug-Resistant Parasite | ACS Omega

Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood Cells | ACS Infectious Diseases
Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood Cells | ACS Infectious Diseases

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance | Nature Communications
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance | Nature Communications

Could Chloroquine Treat Coronavirus? - Scientific American
Could Chloroquine Treat Coronavirus? - Scientific American

Clinical trial launches to evaluate antimalarial drugs for COVID-19 treatment – Washington University School of Medicine in St. Louis
Clinical trial launches to evaluate antimalarial drugs for COVID-19 treatment – Washington University School of Medicine in St. Louis

New method for producing malaria drug at large scales - Science & research news | Frontiers
New method for producing malaria drug at large scales - Science & research news | Frontiers

Long-Term Health Effects of Antimalarial Drugs | National Academies
Long-Term Health Effects of Antimalarial Drugs | National Academies

Antibiotics | Free Full-Text | Next-Generation Human Liver Models for Antimalarial Drug Assays
Antibiotics | Free Full-Text | Next-Generation Human Liver Models for Antimalarial Drug Assays

Novel-Antimalarial-Agent-New-Mode
Novel-Antimalarial-Agent-New-Mode

What is malaria? Facts, symptoms, and how to help | World Vision
What is malaria? Facts, symptoms, and how to help | World Vision

Small Chloroquine Study Halted Over Risk of Fatal Heart Complications - The New York Times
Small Chloroquine Study Halted Over Risk of Fatal Heart Complications - The New York Times

Understanding Private Sector Antimalarial Distribution Chains: A Cross-Sectional Mixed Methods Study in Six Malaria-Endemic Countries | PLOS ONE
Understanding Private Sector Antimalarial Distribution Chains: A Cross-Sectional Mixed Methods Study in Six Malaria-Endemic Countries | PLOS ONE

Host-directed therapy, an untapped opportunity for antimalarial intervention - ScienceDirect
Host-directed therapy, an untapped opportunity for antimalarial intervention - ScienceDirect

Antimalarial Drugs Market Size, Share | Industry Report 2026
Antimalarial Drugs Market Size, Share | Industry Report 2026

WHO and partners take on malaria: the top killer in north-eastern Nigeria
WHO and partners take on malaria: the top killer in north-eastern Nigeria

Effectiveness of Antimalarial Drugs | NEJM
Effectiveness of Antimalarial Drugs | NEJM

Antimalarial Pyrido[1,2-a]benzimidazoles Exert Strong Parasiticidal Effects by Achieving High Cellular Uptake and Suppressing Heme Detoxification | ACS Infectious Diseases
Antimalarial Pyrido[1,2-a]benzimidazoles Exert Strong Parasiticidal Effects by Achieving High Cellular Uptake and Suppressing Heme Detoxification | ACS Infectious Diseases

Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection ...
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection ...